Hidradenitis suppurativa, also known as HS, is a skin condition that causes small, painful lumps under the skin. HS lesions typically occur in areas of the body where skin rubs together, such as the armpits and groin.
Qualified participants may receive compensation for time and travel; be seen by a dermatologist at no cost and have access to medication for hidradenitis suppurativa.
To qualify for this clinical trial, applicants must be between 18 to 75 years of age, be diagnosed with HS for at least one year, have HS lesions in at least two areas of the body, and must not be diagnosed with any other significant skin conditions.
More information about this study is available by calling 813.264.2155 and by visiting http://bit.ly/HSForCareStudy.
Located at 15416 North Florida Ave., Tampa, 33613, FCR is an independent, multi-specialty clinical research facility. Since its inception in 2012, FCR has focused on providing access to novel treatment and therapies for both chronic and acute conditions. FCR investigators have more than 40 years of combined research experience and a proven record of successful execution of Phase I through Phase IV industry-led trials. Additionally, FCR investigators are board certified in dermatology, rheumatology, internal medicine, family practice, anatomic pathology, dermatopathology and internal medicine.
FCR is also conducting studies to test treatments for Vitiligo, Alopecia Areata and Atopic Dermatitis. More information is available online athttps://forcaremed.com/clinical-research/.